Need: A Finnish company based in Espoo, needed partnerships and close collaboration with the medical doctors and molecular genetics laboratories in Ghana to allow their products to be adapted in Ghana to the needs of the ever-evolving field of next-generation sequencing.
Key benefits: Ability to make an informed investment decision based on market potential and development estimates, and to formulate a business strategy based on attractiveness analysis
Application: Strategic Planning
Expert interviews enabled estimating the market potential for the product in the targeted industry. Secondary research was conducted to validate the findings.
Methods: Secondary research and expert interviews across various areas.
The feasibility report of this potential market was delivered to the customer for the next step of action.